pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
hydroxyprogesterone caproate
Hydroxyprogesterone Caproate (hydroxyprogesterone caproate [INN])
Premature Labor (Tocolysis)
$LPCNLipocine Inc.
0 catalysts
Marketed
hydroxyurea
Xromi (hydroxyurea)
Sickle Cell Disease With Vaso-Occlusive Crisis
Nova Laboratories Ltd
0 catalysts
Phase 3
hypericin sodium
Cutaneous T-Cell Lymphoma
$SNGXSOLIGENIX, INC.
0 catalysts
← prev
page 48 of 62
next →
131
Pain89
Neurology1
Phase 2
iadademstat
iadademstat [INN]
Small-Cell Lung Cancer
Oryzon Genomics SA
0 catalysts
Phase 2
ibcasertib
ibcasertib [INN]
Breast Cancer
Shenzhen Chipscreen Biosciences Co Ltd
0 catalysts
Phase 3
ibrilatazar
ibrilatazar [INN]
Metastatic Pancreatic Cancer
Ability Pharmaceuticals SL
0 catalysts
Marketed
ibritumomab tiuxetan
Zevalin (ibritumomab tiuxetan)
B-Cell Non-Hodgkin Lymphoma
Acrotech Biopharma Inc
0 catalysts
Marketed
ibrutinib
Imbruvica (ibrutinib)
Follicular Lymphoma
Tyrosine-protein kinase BTK
$ABBVAbbVie Inc.
0 catalysts
Phase 3
ibudilast
ibudilast [INN]
Amyotrophic Lateral Sclerosis
$MNOVMEDICINOVA INC
0 catalysts
Marketed
idecabtagene vicleucel
Abecma (idecabtagene vicleucel)
Refractory Multiple Myeloma
Celgene Corp
0 catalysts
Phase 2
idroxioleic acid
Malignant Glioma
Laminar Pharmaceuticals SA
0 catalysts
pre_registration
ifinatamab deruxtecan
Small-Cell Lung Cancer
Daiichi Sankyo Co Ltd
0 catalysts
Phase 2
imifoplatin
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Promontory Therapeutics Inc
0 catalysts
Phase 2
imneskibart
Colorectal Cancer
Aulos Bioscience Inc
0 catalysts
Phase 2
imzokitug
Colorectal Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
inlexisertib
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals Inc
0 catalysts
Phase 2
inobrodib
Refractory Multiple Myeloma
CellCentric Ltd
0 catalysts
Marketed
inotuzumab ozogamicin
Besponsa (inotuzumab ozogamicin)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$PFEPFIZER INC
0 catalysts
Marketed
interferon alfa-2b
Intron A (interferon alfa-2b)
Genital Warts (Condylomata Acuminata)
Schering-Plough Corp (Inactive)
0 catalysts
Phase 2
intismeran autogene
Metastatic Melanoma
$MRNAModerna, Inc.
0 catalysts
Phase 2
invikafusp alfa
invikafusp alfa [INN]
Triple-Negative Breast Cancer (TNBC)
Marengo Therapeutics Inc
0 catalysts
Phase 2
iobenguane I 131
Neuroblastoma
Sodium-dependent noradrenaline transporter
Jubilant DraxImage Inc
0 catalysts
Phase 3
iodine i 131 apamistamab
Iomab-B (iodine i 131 apamistamab)
Refractory Acute Myeloid Leukemia
$ATNMActinium Pharmaceuticals, Inc.
0 catalysts
Phase 2
iodofalan I 131
Recurrent Glioblastoma Multiforme (GBM)
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 2
iopofosine i-131
Multiple Myeloma (Kahler Disease)
$CLRBCellectar Biosciences, Inc.
0 catalysts
Phase 3
ipilimumab + nivolumab
Opdivo + Yervoy (ipilimumab + nivolumab)
Gastric Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
irinotecan
irinotecan [INN]
Gastric Cancer
Ascelia Pharma AB
0 catalysts
pre_registration
isatuximab
Sarclisa (isatuximab-irfc)
Refractory Multiple Myeloma
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
$SNYSanofi
0 catalysts
Marketed
istradefylline
Nourianz (istradefylline)
Parkinson's Disease
Kyowa Hakko USA Inc
0 catalysts
Marketed
itraconazole
Tolsura (itraconazole)
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndr…
Lanosterol 14-alpha demethylase
$INTIInhibitor Therapeutics, Inc.
0 catalysts